BNP Paribas Financial Markets Sells 42,258 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)
BNP Paribas Financial Markets decreased its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 42.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 57,830 shares of the biotechnology company’s stock after selling 42,258 shares during the quarter. BNP Paribas Financial Markets’ holdings […]
BNP Paribas Financial Markets decreased its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 42.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 57,830 shares of the biotechnology company’s stock after selling 42,258 shares during the quarter. BNP Paribas Financial Markets’ holdings […]
